CVE-2008-3853

Description

Buffer overflow in the DAS server program in the Core DAS function component in IBM DB2 9.1 before FP4a and 9.5 before FP1 allows remote attackers to execute arbitrary code or cause a denial of service (daemon crash) via unspecified vectors. NOTE: this might be related to CVE-2007-3676.

Category

9.3
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 11.29% Top 10%
Vendor Advisory ibm.com Vendor Advisory ibm.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www-1.ibm.com/support/docview.wss?uid=swg21255607 patch
http://www-1.ibm.com/support/docview.wss?uid=swg1IZ12379 patch vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/45141 vdb entry
ftp://ftp.software.ibm.com/ps/products/db2/fixes/english-us/aparlist/db2_v95/APARLIST.TXT
http://www.securityfocus.com/bid/29601 vdb entry patch
http://www-01.ibm.com/support/docview.wss?uid=swg1IZ12406 vendor advisory
http://secunia.com/advisories/29784 third party advisory

Frequently Asked Questions

What is the severity of CVE-2008-3853?
CVE-2008-3853 has been scored as a critical severity vulnerability.
How to fix CVE-2008-3853?
To fix CVE-2008-3853, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-3853 being actively exploited in the wild?
It is possible that CVE-2008-3853 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~11% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.